Page last updated: 2024-09-03

troxacitabine and Liver Neoplasms

troxacitabine has been researched along with Liver Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bussom, S; Cheng, YC; Lam, W; Leung, CH1
Cheng, YC; Chu, CK; Gao, Z; Grove, KL; Guo, X; Liu, SH1

Other Studies

2 other study(ies) available for troxacitabine and Liver Neoplasms

ArticleYear
The impact of hypoxic treatment on the expression of phosphoglycerate kinase and the cytotoxicity of troxacitabine and gemcitabine.
    Molecular pharmacology, 2007, Volume: 72, Issue:3

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma; Carcinoma, Hepatocellular; Cell Hypoxia; Cell Line, Tumor; Colonic Neoplasms; Cytosine; Deoxycytidine; Dioxolanes; DNA-(Apurinic or Apyrimidinic Site) Lyase; Gemcitabine; Humans; Liver Neoplasms; Pancreatic Neoplasms; Phosphoglycerate Kinase; Rhabdomyosarcoma

2007
Anticancer activity of beta-L-dioxolane-cytidine, a novel nucleoside analogue with the unnatural L configuration.
    Cancer research, 1995, Jul-15, Volume: 55, Issue:14

    Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Division; Colonic Neoplasms; Cytarabine; Cytosine; Dioxolanes; Drug Screening Assays, Antitumor; Humans; KB Cells; Leukemia P388; Liver Neoplasms; Male; Mice; Molecular Structure; Phosphorylation; Prostatic Neoplasms; Stereoisomerism; Tumor Cells, Cultured

1995